You are here

  • Home
  • Archive
  • Volume 60, Issue 5
  • UK consensus recommendations for clinical management of cancer risk for women with germline pathogenic variants in cancer predisposition genes: RAD51C, RAD51D, BRIP1 and PALB2

Citation Tools

Article menu

Download PDFPDF

Position statement
UK consensus recommendations for clinical management of cancer risk for women with germline pathogenic variants in cancer predisposition genes: RAD51C, RAD51D, BRIP1 and PALB2

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Hanson H, Kulkarni A, Loong L, et al
UK consensus recommendations for clinical management of cancer risk for women with germline pathogenic variants in cancer predisposition genes: RAD51C, RAD51D, BRIP1 and PALB2
Journal of Medical Genetics 2023;60:417-429.